Terms: = Liver cancer AND TRA AND Treatment
24 results:
1. Per-patient Negative Predictive Value of the CT and MRI liver Imaging Reporting and Data System Version 2018 treatment Response Algorithm for Hepatocellular Carcinoma.
Hassan OT; Behr SC; Ohliger MA; Fowler KJ; Gill RM; Fidelman N; Mehta N; Choi HH
Radiology; 2023 Dec; 309(3):e222776. PubMed ID: 38112541
[TBL] [Abstract] [Full Text] [Related]
2. French Interventional Radiology Centers' Uptake of transradial Approach and Outpatient Hepatocellular Carcinoma Intra-Arterial treatments.
Grégory J; Ronot M; Laurent V; Chabrot P; de Baere T; Chevallier P; Vilgrain V; Aubé C;
Cardiovasc Intervent Radiol; 2024 Apr; 47(4):432-440. PubMed ID: 37930400
[TBL] [Abstract] [Full Text] [Related]
3. Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy.
Stocker D; King MJ; Homsi ME; Gnerre J; Marinelli B; Wurnig M; Schwartz M; Kim E; Taouli B
Eur Radiol; 2024 Jan; 34(1):475-484. PubMed ID: 37540318
[TBL] [Abstract] [Full Text] [Related]
4. Updates on LI-RADS treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI.
Patel R; Aslam A; Parikh ND; Mervak B; Mubarak E; Higgins L; Lala K; Conner JF; Khaykin V; Bashir M; Do RKG; Burke LMB; Smith EN; Kim CY; Shampain KL; Owen D; Mendiratta-Lala M
J Magn Reson Imaging; 2023 Jun; 57(6):1641-1654. PubMed ID: 36872608
[TBL] [Abstract] [Full Text] [Related]
5. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
6. Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment.
Seo N; Joo DJ; Park MS; Kim SS; Shin HJ; Chung YE; Choi JY; Kim MS; Kim MJ
Eur Radiol; 2023 Jan; 33(1):501-511. PubMed ID: 35821427
[TBL] [Abstract] [Full Text] [Related]
7. LI-RADS treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.
Mendiratta-Lala M; Aslam A; Maturen KE; Westerhoff M; Maurino C; Parikh ND; Sun Y; Sonnenday CJ; Stein EB; Shampain KL; Kaza RK; Cuneo K; Masch W; Do RKG; Lawrence TS; Owen D
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):704-714. PubMed ID: 34644607
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of the LI-RADS treatment response algorithm in hepatocellular carcinoma after trans-arterial chemoembolization.
Kierans AS; Najjar M; Dutruel SP; Gavlin A; Chen C; Lee MJ; Askin G; Halazun KJ
Clin Imaging; 2021 Dec; 80():117-122. PubMed ID: 34303189
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Hepatocellular Carcinoma treatment Response After Locoregional Therapy.
Kampalath R; Tran-Harding K; Do RKG; Mendiratta-Lala M; Yaghmai V
Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):389-403. PubMed ID: 34243925
[TBL] [Abstract] [Full Text] [Related]
10. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS treatment Response Assessment Criteria.
Bajaj G; Sundaram K; Jambhekar K; Ram R
Semin Ultrasound CT MR; 2021 Aug; 42(4):318-331. PubMed ID: 34130846
[TBL] [Abstract] [Full Text] [Related]
11. LI-RADS treatment response lexicon: review, refresh and resolve with emerging data.
Ram R; Kampalath R; Shenoy-Bhangle AS; Arora S; Kielar AZ; Mendiratta-Lala M
Abdom Radiol (NY); 2021 Aug; 46(8):3549-3557. PubMed ID: 34106301
[TBL] [Abstract] [Full Text] [Related]
12. LI-RADS Version 2018 treatment Response Algorithm: Diagnostic Performance after transarterial Radioembolization for Hepatocellular Carcinoma.
Yoon J; Lee S; Shin J; Kim SS; Kim GM; Won JY
Korean J Radiol; 2021 Aug; 22(8):1279-1288. PubMed ID: 33987991
[TBL] [Abstract] [Full Text] [Related]
13. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.
Aslam A; Kamath A; Spieler B; Maschiocchi M; Sabottke CF; Chernyak V; Lewis SC
Abdom Radiol (NY); 2021 Aug; 46(8):3565-3578. PubMed ID: 33856509
[TBL] [Abstract] [Full Text] [Related]
14. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients.
Granata V; Grassi R; Fusco R; Setola SV; Belli A; Piccirillo M; Pradella S; Giordano M; Cappabianca S; Brunese L; Grassi R; Petrillo A; Izzo F
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808466
[TBL] [Abstract] [Full Text] [Related]
15. Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Spieler B; Sabottke C; Moawad AW; Gabr AM; Bashir MR; Do RKG; Yaghmai V; Rozenberg R; Gerena M; Yacoub J; Elsayes KM
Abdom Radiol (NY); 2021 Aug; 46(8):3660-3671. PubMed ID: 33786653
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of LI-RADS Version 2018 treatment Response Algorithm for Hepatocellular Carcinoma in liver transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract] [Full Text] [Related]
17. transradial Access Chemoembolization for Hepatocellular Carcinoma Patients.
Du N; Ma J; Yang M; Zhang Z; Zheng Z; Zhang W; Yan Z
J Vis Exp; 2020 Sep; (163):. PubMed ID: 33016947
[TBL] [Abstract] [Full Text] [Related]
18. The LI-RADS Version 2018 MRI treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
Chaudhry M; McGinty KA; Mervak B; Lerebours R; Li C; Shropshire E; Ronald J; Commander L; Hertel J; Luo S; Bashir MR; Burke LMB
Radiology; 2020 Feb; 294(2):320-326. PubMed ID: 31845843
[TBL] [Abstract] [Full Text] [Related]
19. transradial versus transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study.
Iezzi R; Pompili M; Posa A; Annicchiarico E; Garcovich M; Merlino B; Rodolfino E; Di Noia V; Basso M; Cassano A; Barone C; Gasbarrini A; Manfredi R; Colosimo C
J Vasc Interv Radiol; 2017 Sep; 28(9):1234-1239. PubMed ID: 28757286
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and identification of induced pluripotent stem cells in liver cancer patients.
Zhang DM; Li JJ; Yan P; Hu JT
Asian Pac J Trop Med; 2014 Apr; 7(4):253-6. PubMed ID: 24507670
[TBL] [Abstract] [Full Text] [Related]
[Next]
